BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yoon HA, Noh MH, Kim BG, Han JS, Jang JS, Choi SR, Jeong JS, Chun JH. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma. World J Gastroenterol 2011; 17(35): 4023-4030 [PMID: 22046092 DOI: 10.3748/wjg.v17.i35.4023]
URL: https://www.wjgnet.com/1007-9327/full/v17/i35/4023.htm
Number Citing Articles
1
Xiaolei Liu, Jia Huang, Liguo Liu, Rong Liu. MPZL1 is highly expressed in advanced gallbladder carcinoma and promotes the aggressive behavior of human gallbladder carcinoma GBC‑SD cellsMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10506
2
Hong-Beum Kim, Won Jin Cho, Nam Gyu Choi, Sung-Soo Kim, Jun Hee Park, Hee-Jeong Lee, Sang Gon Park. Clinical implications of APEX1 and Jagged1 as chemoresistance factors in biliary tract cancerAnnals of Surgical Treatment and Research 2017; 92(1): 15 doi: 10.4174/astr.2017.92.1.15
3
Wen-Cheng Chung, Junqing Wang, Yunyun Zhou, Keli Xu. KrasG12D upregulates Notch signaling to induce gallbladder tumorigenesis in miceOncoscience 2017; 4(9-10): 131 doi: 10.18632/oncoscience.368
4
Daniel H. Ahn, Tanios Bekaii-Saab. Textbook of Gastrointestinal Oncology2019; : 185 doi: 10.1007/978-3-030-18890-0_11
5
Amir A. Rahnemai-Azar, Timothy M. Pawlik. Cholangiocarcinoma: shedding light on the most promising drugs in clinical developmentExpert Opinion on Investigational Drugs 2021; 30(4): 419 doi: 10.1080/13543784.2021.1897103
6
Toshio Kokuryo, Yukihiro Yokoyama, Masato Nagino. Recent advances in cancer stem cell research for cholangiocarcinomaJournal of Hepato-Biliary-Pancreatic Sciences 2012; 19(6): 606 doi: 10.1007/s00534-012-0542-6
7
Paxton V. Dickson, Stephen W. Behrman. Distal CholangiocarcinomaSurgical Clinics of North America 2014; 94(2): 325 doi: 10.1016/j.suc.2013.12.004
8
Hakan Soylu, Nuray Acar, Ozlem Ozbey, Betul Unal, Ismail Turker Koksal, Ibrahim Bassorgun, Akif Ciftcioglu, Ismail Ustunel. Characterization of Notch Signalling Pathway Members in Normal Prostate, Prostatic Intraepithelial Neoplasia (PIN) and Prostatic AdenocarcinomaPathology & Oncology Research 2016; 22(1): 87 doi: 10.1007/s12253-015-9983-y
9
Javier Vaquero, Nathalie Guedj, Audrey Clapéron, Thanh Huong Nguyen Ho-Bouldoires, Valérie Paradis, Laura Fouassier. Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networksJournal of Hepatology 2017; 66(2): 424 doi: 10.1016/j.jhep.2016.09.010
10
Jason K. Sicklick, Paul T. Fanta. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set2017; : 150 doi: 10.1016/B978-0-323-34062-5.00122-9
11
Amartej Merla, Kenneth G. Liu, Lakshmi Rajdev. Targeted Therapy in Biliary Tract CancersCurrent Treatment Options in Oncology 2015; 16(10) doi: 10.1007/s11864-015-0366-0
12
Abigail Zabron, Robert J. Edwards, Shahid A. Khan. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancerDisease Models & Mechanisms 2013; 6(2): 281 doi: 10.1242/dmm.010561
13
Soomin Ahn, Jiyeon Hyeon, Cheol-Keun Park. Notchl and Notch4 are markers for poor prognosis of hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2013; 12(3): 286 doi: 10.1016/S1499-3872(13)60046-6
14
P. Baichan, P. Naicker, J. W. S. Devar, M. Smith, G. P. Candy, E. Nweke. Targeting gallbladder cancer: a pathway based perspectiveMolecular Biology Reports 2020; 47(3): 2361 doi: 10.1007/s11033-020-05269-x
15
Meng-Xi Xiu, Yuan-Meng Liu, Bo-hai Kuang. <p>The Role of DLLs in Cancer: A Novel Therapeutic Target</p>OncoTargets and Therapy 2020; : 3881 doi: 10.2147/OTT.S244860
16
Carolina Bizama, Patricia García, Jaime A. Espinoza, Helga Weber, Pamela Leal, Bruno Nervi, Juan Carlos Roa. Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapyCancer Treatment Reviews 2015; 41(3): 222 doi: 10.1016/j.ctrv.2015.01.003
17
Mariana Verdelho Machado, Anna Mae Diehl. The Liver2020; : 539 doi: 10.1002/9781119436812.ch43
18
Francesca Borlak, Anja Reutzel-Selke, Anja Schirmeier, Julia Gogolok, Ellen von Hoerschelmann, Igor M. Sauer, Johann Pratschke, Marcus Bahra, Rosa B. Schmuck. Notch Signaling Pathway in Pancreatobiliary TumorsMedicina 2021; 57(2): 105 doi: 10.3390/medicina57020105
19
Benjamin Rahmani, Jason Gandhi, Gunjan Joshi, Noel L. Smith , Inefta Reid , Sardar Ali Khan. The Role of Diabetes Mellitus in Diseases of the Gallbladder and Biliary TractCurrent Diabetes Reviews 2020; 16(9): 931 doi: 10.2174/1573399816666200305094727
20
Hee Jin Lee, Dae-Woon Eom, Gil Hyun Kang, Sang Hak Han, Gab Jin Cheon, Ho-Suk Oh, Koon Hee Han, Heui June Ahn, Hyuk-Jai Jang, Myoung Sik Han. Colorectal micropapillary carcinomas are associated with poor prognosis and enriched in markers of stem cellsModern Pathology 2013; 26(8): 1123 doi: 10.1038/modpathol.2012.163
21
Shuichi Aoki, Masamichi Mizuma, Yayoi Takahashi, Yoichi Haji, Ryo Okada, Tomoya Abe, Hideaki Karasawa, Keiichi Tamai, Takaho Okada, Takanori Morikawa, Hiroki Hayashi, Kei Nakagawa, Fuyuhiko Motoi, Takeshi Naitoh, Yu Katayose, Michiaki Unno. Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like propertiesBMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2919-4
22
WEN-RUI WU, RUI ZHANG, XIANG-DE SHI, MAN-SHENG ZHU, LEI-BO XU, HONG ZENG, CHAO LIU. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitroOncology Reports 2014; 31(6): 2515 doi: 10.3892/or.2014.3123
23
Fernando Ortiz-Martínez, Francisco José Gutiérrez-Aviñó, Elena Sanmartín, Eloy Pomares-Navarro, Cristina Villalba-Riquelme, Araceli García-Martínez, Enrique Lerma, Gloria Peiró. Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3+ TregsExperimental and Molecular Pathology 2016; 100(3): 460 doi: 10.1016/j.yexmp.2016.04.006
24
Jacklyn M. Nemunaitis, Ursa Brown-Glabeman, Heloisa Soares, Jessica Belmonte, Ben Liem, Itzhak Nir, Victor Phuoc, Rama R. Gullapalli. Gallbladder cancer: review of a rare orphan gastrointestinal cancer with a focus on populations of New MexicoBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4575-3
25
Peter L. Labib, George Goodchild, Stephen P. Pereira. Molecular Pathogenesis of CholangiocarcinomaBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5391-0
26
Biao Fan, Yann Malato, Diego F. Calvisi, Syed Naqvi, Nataliya Razumilava, Silvia Ribback, Gregory J. Gores, Frank Dombrowski, Matthias Evert, Xin Chen, Holger Willenbring. Cholangiocarcinomas can originate from hepatocytes in miceJournal of Clinical Investigation 2012; 122(8): 2911 doi: 10.1172/JCI63212
27
Kara M. Keplinger, Mark Bloomston. Anatomy and Embryology of the Biliary TractSurgical Clinics of North America 2014; 94(2): 203 doi: 10.1016/j.suc.2014.01.001
28
Jurairat Jongthawin, Porncheera Chusorn, Anchalee Techasen, Watcharin Loilome, Thidarut Boonmars, Raynoo Thanan, Anucha Puapairoj, Narong Khuntikeo, Wichittra Tassaneeyakul, Puangrat Yongvanit, Nisana Namwat. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progressionTumor Biology 2014; 35(8): 8051 doi: 10.1007/s13277-014-2021-y
29
Mona El Khatib, Przemyslaw Bozko, Vindhya Palagani, Nisar P. Malek, Ludwig Wilkens, Ruben R. Plentz, Peiwen Fei. Activation of Notch Signaling Is Required for Cholangiocarcinoma Progression and Is Enhanced by Inactivation of p53 In VivoPLoS ONE 2013; 8(10): e77433 doi: 10.1371/journal.pone.0077433